---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-24-000159"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T18:17:24.563816+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Renovaro shareholders approve all proposals to advance GEDi Cube acquisition

## Summary
- Shareholders approved share issuance for GEDi Cube Intl Ltd acquisition under Stock Purchase Agreement.
- Authorized capital stock increased from 110M to 360M shares; common stock from 100M to 350M.
- Approved decrease of exercise price for outstanding stock options to closing price on deal date.
- Approved 5M share increase for awards under 2023 Equity Incentive Plan.
- All five proposals passed with strong support; over 46% voting power represented at meeting.

## SEC filing metadata
- accession: 0001731122-24-000159
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000159/0001731122-24-000159-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000159/e5384_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-24-000159
- JSON: https://secwatch.observer/filing/0001731122-24-000159.json
- Plain text: https://secwatch.observer/filing/0001731122-24-000159.txt

## Key facts
- Shareholder Votes
  Lunai Bioworks Inc. shareholders approved Approval of issuance of shares of Common Stock pursuant to the Stock Purchase Agreement at the 2024-01-25 meeting.
  - Proposal: merger approval
  - Outcome: passed
  - Meeting: 2024-01-25
  source text: Proposal No. 1 : Approval, for purposes of Listing Rule 5635 of The Nasdaq Stock Market LLC (“Nasdasq”), of the issuance of shares of Common Stock , pursuant to the Stock Purchase Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000159/0001731122-24-000159-index.htm
- Shareholder Votes
  Lunai Bioworks Inc. shareholders approved Amendment to increase authorized shares of capital stock at the 2024-01-25 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2024-01-25
  source text: Proposal No. 2 : Approval of an amendment to Renovaro’s Certificate of Incorporation, as amended, to increase the total number of authorized shares of capital stock of Renovaro from one hundred ten million (110,000,000) to three hundred sixty million (360,000,000)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000159/0001731122-24-000159-index.htm
- Shareholder Votes
  Lunai Bioworks Inc. shareholders approved Amendment to 2023 Plan to increase shares available for awards by 5,000,000 at the 2024-01-25 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2024-01-25
  source text: Proposal No. 4 : Approval of an amendment to the 2023 Plan to increase the number of shares of Common Stock available for awards under the 2023 Plan by five million (5,000,000) shares . The stockholders approved this proposal as follows: Votes For 32,145,204 Votes Against 45,717 Abstentions 2,601 Broker Non-Votes 1,394,478
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000159/0001731122-24-000159-index.htm
- Shareholder Votes
  Lunai Bioworks Inc. shareholders approved Approval to adjourn meeting if necessary for proxy solicitation at the 2024-01-25 meeting.
  - Outcome: passed
  - Meeting: 2024-01-25
  source text: Proposal No. 5 : Approval to adjourn the Meeting, if necessary, for the purpose of soliciting additional proxies to approve any one or more of the foregoing proposals to be considered at the Meeting
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000159/0001731122-24-000159-index.htm
- Shareholder Votes
  Lunai Bioworks Inc. shareholders approved Decrease in exercise price of outstanding stock options under the 2019 and 2023 Equity Incentive Plans at the 2024-01-25 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2024-01-25
  source text: Proposal No. 3 : Approval of a decrease in the exercise price of the outstanding stock options held by Renovaro’s employees and consultants granted pursuant to the Enochian BioSciences Inc. 2019 Equity Incentive Plan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000159/0001731122-24-000159-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.